All News

Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility do not appear to improve pregnancy rates.

The final weeks of 2019 saw high seasonal influenza activity across the United States, and the CDC said it continues to increase, according to the Weekly Influenza Surveillance Report for the week ending in December 28, 2019.

Under this policy, companies that do not cease manufacture, distribution, and sale of unauthorized flavored cartridge-based e-cigarettes within 30 days risk enforcement actions by the federal agency.

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

The study analyzed 368 mothers and their children during pregnancy, and when the children were ages 3 and 7 years.

From newsworthy moments to groundbreaking research, here are the most popular articles published by Contemporary Clinic during 2019:

Officials with the FDA have approved Eisai’s lemborexant (Dayvigo) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Tazarotene is the first acne treatment to be available in a lotion form, showing strong efficacy with favorable tolerability, according to the company.

When comparing men and women with PTSD, the study found that having PTSD had more of an effect on a woman’s risk for several kinds of infection than on a man’ risk, for example, urinary tract infections.

The FDA has granted Fast Track Designation for lebrikizumab (Dermira) to treat patients with moderate-to-severe atopic dermatitis (AD).

The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).

The FDA has approved the Unidose Liquid System (AptarGroup Inc) as the first and only nasal rescue treatment for acute repetitive seizures in patients with epilepsy.

Death by external causes—primarily accidents and suicide—take the lives of more than 5 million people each year, and it has evolved into a major health concern on a global scale. External causes also include violence, undetermined causes, and medical procedures.

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

In partnership with a team of medical centers, universities, and private industries, Emmes, a scientific research company, will support the development of a “universal influenza vaccine” that could provide longer-lasting protection than the current vaccines available, according to a company press release. The vaccine would also combat a wider variety of influenza viruses.

Staying on top of oral hygiene may be connected to a lower risk of atrial fibrillation (AF) and heart failure (HF), according to a new study published in the European Journal of Preventive Cardiology.

Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.

A study published in September 2019 in the New England Journal of Medicine has found that patients HF with reduced ejection fraction (HFrEF) receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular causes.

Starting December 2, midazolam (Nayzilam, UCB) will be available at retail pharmacies for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern with epilepsy.

Each November, members of the chronic obstructive pulmonary disease (COPD) community come together to focus on increasing awareness of the respiratory condition.

The FDA has approved cenobamate tablets (XCOPRI, SK Life Sciences) for treatment of partial-onset seizures in adults.

Tafenoquine (Arakoda), the first prescription drug approved for the prevention of malaria in adults, is now available in the United States, according to a press release. Tafenoquine has the potential to protect thousands of US travelers and military personnel from the effects of malaria.

The 24-hour telehealth option is available 7 days a week to people with minor illnesses, minor injuries, and skin conditions.

Officials from the FDA have approved MiSight 1-day contact lenses (CooperVision), a daily wear, single use contact lens indicated for the use of myopia management. This is the first and only FDA-approved product clinically proven to slow the progression of myopia, or near-sightedness, when initially prescribed for children 8-12 years old.

The shoe is designed to be easy to clean, simple to take on and off, and equipped with fit, cushioning, and traction systems to meet physical and mental hospital conditions.

Scholastic, the children’s publishing and media company, is working with the FDA to develop new youth e-cigarette prevention resources for schools and have launched the first resources for middle school students.

According to a study published by JAMA Dermatology, cases of melanoma in the United States among adolescents and young adults has declined from 2006-2015, suggesting that public-health efforts advocating sun protection are changing behaviors among the younger generations.

This test is intended to revolutionize the speed and accuracy for patients who are experiencing symptoms of Lyme disease.

A study conducted by the Uniting Medically Supervised Injecting Centre in Sydney, Australia found that intranasally administered naloxone can reverse opioid overdose, but not as efficiently as intramuscularly administered naloxone can.

Louisiana and Nevada show the highest flu activity in the first monthly report from the Walgreens Flu Index for October, which shows increased incidence of the flu compared with last year.